Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 16, Issue 1, 2013, Pages 35-40

  Vasiljevic N ^a   Ahmad, A S ^a   Beesley, C ^b   Thorat, M A ^a   Fisher, G ^a   Berney, D M ^a   Moller H ^c   Yu, Y ^d   Lu, Y J ^a   Cuzick, J ^a   Foster, C S ^b   Lorincz, A T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

biomarker; Hsp 27; HSPB1; methylation

Indexed keywords

HEAT SHOCK PROTEIN 27;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CPG ISLAND; DISEASE MARKER; DNA METHYLATION; EXON; GENE EXPRESSION; GLEASON SCORE; HSPB1 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PYROSEQUENCING; RELIABILITY; RNA TRANSLATION; SENSITIVITY AND SPECIFICITY;

BLOTTING, WESTERN; CPG ISLANDS; DNA METHYLATION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRONS; MALE; NEOPLASM GRADING; POLYMERASE CHAIN REACTION; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873728971     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2012.47     Document Type: Article

References (30)

1. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60: 7099-7105. (Pubitemid 32059190)
2. Foster CS, Dodson AR, Ambroisine L, Fisher G, Moller H, Clark J et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer 2009; 101: 1137-1144.
3. Glaessgen A, Jonmarker S, Lindberg A, Nilsson B, Lewensohn R, Ekman P et al. Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. Apmis 2008; 116: 888-895.
4. Miyake H, Muramaki M, Kurahashi T, Takenaka A, Fujisawa M. Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Urol Oncol 2010; 28: 145-151.
5. O'Neill PA, Shaaban AM, West CR, Dodson A, Jarvis C, Moore P et al. Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer 2004; 90: 182-188. (Pubitemid 38174959)
6. Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK et al. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut 2010; 59: 1501-1510.
7. Coupland SE, Vorum H, Mandal N, Kalirai H, Honore B, Urbak SF et al. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci 2010; 51: 12-20.
8. Gibbons NB, Watson RW, Coffey RN, Brady HP, Fitzpatrick JM. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 2000; 45: 58-65.
9. Rocchi P, Jugpal P, So A, Sinneman S, Ettinger S, Fazli L et al. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. BJU Int 2006; 98: 1082-1089. (Pubitemid 44536463)
10. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001; 286: 433-442. (Pubitemid 32912965)
11. Geisler JP, Tammela JE, Manahan KJ, Geisler HE, Miller GA, Zhou Z et al. HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up. Eur J Gynaecol Oncol 2004; 25: 165-168. (Pubitemid 38268689)
12. Thanner F, Sutterlin MW, Kapp M, Rieger L, Morr AK, Kristen P et al. Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients. Anticancer Res 2005; 25: 1649-1653. (Pubitemid 40896778)
13. Ono A, Kumai T, Koizumi H, Nishikawa H, Kobayashi S, Tadokoro M. Over-expression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues. Hum Pathol 2009; 40: 41-49.
14. Morino M, Tsuzuki T, Ishikawa Y, Shirakami T, Yoshimura M, Kiyosuke Y et al. Specific expression of HSP27 in human tumor cell lines in vitro. In Vivo 1997; 11: 179-184. (Pubitemid 27219890)
15. Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res 2004; 64: 6595-6602. (Pubitemid 39297919)
16. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10: 295-304.
17. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991; 48: 880-888. (Pubitemid 21891632)
18. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054. (Pubitemid 37448928)
19. Cuzick J, Fisher G, Kattan MW, Berney D, Oliver T, Foster CS et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 2006; 95: 1186-1194. (Pubitemid 44658482)
20. Vasiljevic N, Wu K, Brentnall AR, Kim DC, Thorat M, Kudahetti SC et al. Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers 2011; 30: 151-161.
21. Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol 2011; 12: 245-255.
22. Yao S, Bee A, Brewer D, Dodson A, Beesley C, Ke Y et al. PRKC-z expression promotes the aggressive phenotype of human prostate cancer cells and is a novel target for therapeutic intervention. Genes Cancer 2010; 1: 444-464.
23. Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T et al. Distinct genomic alterations in prostate cancers in Chinese and western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res 2010; 70: 13.
24. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinfor-matics 2002; 18: 1427-1431. (Pubitemid 35414532)
25. Janssen KJ, Donders AR, Harrell Jr. FE, Vergouwe Y, Chen Q, Grobbee DE et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010; 63: 721-727.
26. Oesterreich S, Hickey E, Weber LA, Fuqua SA. Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells. Biochem Biophys Res Commun 1996; 222: 155-163. (Pubitemid 26152221)
27. Hickey E, Brandon SE, Potter R, Stein G, Stein J, Weber LA. Sequence and organization of genes encoding the human 27 kDa heat shock protein. Nucleic Acids Res 1986; 14: 4127-4145.
28. Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 2001; 93: 1465-1472. (Pubitemid 32982675)
29. Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM et al. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Eur Urol 2004; 46: 698-708. (Pubitemid 39488398)
30. Phe V, Cussenot O, Roupret M. Methylated genes as potential biomarkers in prostate cancer. BJU Int 2010; 105: 1364-1370.